A new antioxidant nutraceutical compound is able to reduce the level of prostate pro-inflammatory mediators: results from a phase III, placebo controlled trial
- DOI
- 10.4081/aiua.2026.14712
- Published
- 2026-11-09
- Container
- Archivio Italiano di Urologia e Andrologia
- Publisher
- PAGEPress Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4081/aiua.2026.14712,
title = {A new antioxidant nutraceutical compound is able to reduce the level of prostate pro-inflammatory mediators: results from a phase III, placebo controlled trial},
author = {Tommaso Ceccato and Simone Botti and Daniele Mattevi and Luca Gallelli and Sandra Mazzoli and Michele Rizzo and Giovanni Liguori and Fabrizio Palumbo and Alessandro Palmieri and Alessandro Zucchi and Truls Bjerklund Johansen and Tommaso Cai},
year = {2026},
journal = {Archivio Italiano di Urologia e Andrologia},
doi = {10.4081/aiua.2026.14712},
url = {https://doi.org/10.4081/aiua.2026.14712}
}RIS
TY - JOUR TI - A new antioxidant nutraceutical compound is able to reduce the level of prostate pro-inflammatory mediators: results from a phase III, placebo controlled trial AU - Tommaso Ceccato AU - Simone Botti AU - Daniele Mattevi AU - Luca Gallelli AU - Sandra Mazzoli AU - Michele Rizzo AU - Giovanni Liguori AU - Fabrizio Palumbo AU - Alessandro Palmieri AU - Alessandro Zucchi AU - Truls Bjerklund Johansen AU - Tommaso Cai PY - 2026 JO - Archivio Italiano di Urologia e Andrologia DO - 10.4081/aiua.2026.14712 UR - https://doi.org/10.4081/aiua.2026.14712 ER -
APA
Ceccato, T., Botti, S., Mattevi, D., Gallelli, L., Mazzoli, S., Rizzo, M., Liguori, G., Palumbo, F., Palmieri, A., Zucchi, A., Johansen, T. B., & Cai, T. (2026). A new antioxidant nutraceutical compound is able to reduce the level of prostate pro-inflammatory mediators: results from a phase III, placebo controlled trial. Archivio Italiano di Urologia e Andrologia. https://doi.org/10.4081/aiua.2026.14712
Source records
- crossref · retrieved 2026-11-10T12:02:40.875Z